View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 15, 2016updated 13 Jul 2022 10:13am

Planning for Effective Clinical Supply Chain Management

Michael Lee, Plant Director, JHL Biotech, examines ways to achieve operational excellence when managing the clinical supply chain

By Staff Writer

As the pressure to get drugs to market faster increases, sponsor companies are continually evaluating ways on how to clinical trials efficiently. A key aspect of achieving these efficiencies is the effective transformation of the clinical supply chain and its associated processes. Supply Chain Management (SCM) needs a digital and physical solution that is both integrated and seamless.

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

When operating in today’s complex digital and physical environment, there are three fundamental capabilities that biopharma companies need to improve upon to maintain and enhance their SCM performance:

  • Visibility. Better visibility helps the SCM team set priorities and ensure resources are allocated in line with the priorities. It can also smooth the transition from research to manufacturing and commercialization.

  • Traceability. Better traceability improves the organization’s SCM ability to maintain compliance and address regulatory requirements. It also enables improved use of knowledge assets by allowing product development teams to retrace development decisions made in the past.

  • Collaboration. It involves the SCM team partnering with many different organizations. Better collaboration enables a richer understanding of global challenges and creates more SCM solutions.

When examining ways to improve clinical SCM, there are several facets that need to be considered. They are: Business Intelligence collection, Reaching for Commercial Excellence, Pricing and Contracting for SCM, Quality and Compliance, Coordination among R&D / MFG, Practices in assuring Supply Chain Integrity with effective Supply Chain Planning, Product Lifecycle Management (PLM), Supply Chain Collaboration, SCM Systems & Strategy, and Risk Mitigation.

Within every sponsor company, the SCM team is responsible for coordinating:

  • Packaging design
  • SCM Contingency planning
  • Distribution strategy and management
  • QP release
  • Commercial drug procurement
  • Master label text generation and translation

On FORECASTING, SCM team is to follow:

  • Protocol design impact on clinical supplies
  • Scenario planning
  • Review Forecasting vs. Actual drug usage

On SUPPLY CHAIN OVERSIGHT, SCM team is responsible for:

  • Manufacturing and production planning
  • Global inventory management
  • Expiry and re-test management
  • Identifying trends and adjusting plans to optimize supply chain

On DISTRIBUTION MANAGEMENT, the SCM team is to perform on:

  • Shipment quantity optimization
  • Temperature surveillance – end-to-end management
  • Global depot network management

 

Many companies are now recognizing the potential benefits of having a more holistic approach to clinical supplies as it affords the SCM team the ability to monitor supply activities across multiple trials worldwide. Additionally, an all encompassing approach provides a platform to standardize processes while making supply management processes more streamlined.

For efficient delivery of supplies, the SCM team and contractors must have an established transportation and storage infrastructure that includes vetted third-party freight carriers and storage facilities. With solid knowledge of shipping options and current regulatory requirements, they determine the optimal distribution logistics. Key considerations you need to factor are:

  • What are the most effective routes of transportation?
  • Who are the most efficient, reliable freight couriers?
  • Which freight courier is best for a particular shipment?
  • What is the best way to coordinate shipping schedules and manage requirements for air, ocean, and ground transit?
  • Which port of entry has the most efficient government customs clearance process?
  • What special arrangements must be made for time-and temperature-sensitive supplies?
  • Distribution managers should also be knowledgeable about the unique regulatory requirements of each country.

 

Additionally, when it comes to self evaluation, the SCM team must answer the following questions:

  • Do we have tools to connect people and processes, enabling informed decisions for the utmost confidence in the broader supply chain?
  • Are we able to make purchasing choices based on an optimized global plan?
  • Do we combine demand forecasts with a manufacturing bill of materials, processes, efficiency goals and timelines to determine the manufacturing and packaging plan at all material levels?
  • Do we have web-accessible tools for SCM?
  • Can we forecast the supply chain across ALL STUDIES to any level you desire, from Finished Goods to API?
  • Do we know how much drug to manufacture, package, and/or purchase?
  • Do we have an established collaborative environment that makes it easy to share plans with peers, partners, customers and management?
  • Can we forecast supply needs, run simulations, and develop a comprehensive plan with our input?
  • As a study progresses, can our team revisit forecasts using the latest actuals as well as alert ourselves of changes and potential complications?
  • Do we have solutions to enhance and supplement our core manufacturing, packaging and distribution services for investigational products?

 

Planning and managing clinical trials is an increasingly complex task. Unlike standard supply chains, there are many unpredictable factors within clinical material supply chain management. The SCM team needs to reach excellence in clinical supply chain management to maximize operational effectiveness. Achieving excellence and effectiveness will in turn save a company millions of dollars in R&D costs.

Related Companies

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena